usan

Garenoxacin mesylate hydrate (Garenoxacin mesylate [USAN]) with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.

Pibuterol Acetate is a short-acting beta-2 adrenergic receptor agonist with bronchiectasis and is used as a respiratory activated quantitative inhaler in the treatment of asthma.

Besonprodil is a drug that acts as an NMDA antagonist and is selective for the NR2B subunit.

Alatrofloxacin Mesylate is the parental prodrug of broad-spectrum antibiotic trovafloxacin.

Englitazone sodium is an antidiabetic agent and a novel NSCA and KATP channel blocker.

Flumizole is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzyme cyclocxygenase (COX).

Enazadrem phosphate is a bio-active chemical. Detailed information has not been published.

Fanetizole mesylate is an immunoregulator agent.

Effusanin B shows antibacterial activity. It exhibits DNA-damaging activity in assay which employes DNA-repair deficient (RAD 52Y) and repair proficient (RAD +) yeast strains.

Effusanin A has antibacterial activity. It exhibits DNA-damaging activity in assay which employed DNA-repair deficient (RAD 52Y) and repair proficient (RAD +) yeast strains. Effusanin A shows inhibitory effects on DU145 cells with IC50 value of 3.16 micro

Effusanin E shows antibacterial and anti-cancer activities, it significantly inhibits cell proliferation and induces apoptosis in NPC cells by suppressing p50/p65 proteins to down-regulate COX-2 expression .

(Z)-Raphanusanin is a useful organic compound for research related to life sciences. The catalog number is T125809 and the CAS number is 148225-27-8.

Clausantalene is a useful organic compound for research related to life sciences and the catalog number is TSP-43417379.

Cromoglicic acid , cromolyn (USAN), cromoglycate (former BAN), or cromoglicate, is traditionally described as a mast cell stabilizer, and is commonly marketed as the sodium salt sodium cromoglicate or cromolyn sodium. This drug prevents the release of inflammatory chemicals such as histamine from mast cells. Because of their convenience (and perceived safety), leukotriene receptor antagonists have largely replaced it as the non-corticosteroid treatment of choice in the treatment of asthma. Cromoglicic acid requires administration four times daily, and does not provide additive benefit in combination with inhaled corticosteroids.